Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL232221 | 0.81 | KMT2A (0.39) | KMT2AMEN1LMNAMAPTALDH1A1 | |
| SCHEMBL11729034 | 0.79 | LMNA (0.39) | KMT2AMEN1LMNAMAPTALDH1A1 | |
| SCHEMBL27823416 | 0.79 | KMT2A (0.38) | KMT2AMEN1LMNAMAPTALDH1A1 | |
| SCHEMBL300143 | 0.76 | KMT2A (0.41) | KMT2AMEN1LMNAMAPTALDH1A1 | |
| SCHEMBL1477384 | 0.76 | KMT2A (0.41) | KMT2AMEN1LMNAMAPTALDH1A1 | |
| SCHEMBL28486993 | 0.75 | CHRM5 (0.31) | KMT2AMEN1 | |
| SCHEMBL23108665 | 0.73 | KMT2A (0.42) | KMT2AMEN1LMNAMAPTALDH1A1 | |
| SCHEMBL21564194 | 0.73 | KMT2A (0.42) | KMT2AMEN1LMNAMAPTALDH1A1 | |
| SCHEMBL643674 | 0.73 | KMT2A (0.42) | KMT2AMEN1LMNAMAPTALDH1A1 | |
| SCHEMBL8650528 | 0.72 | KMT2A (0.46) | KMT2AMEN1LMNAMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110300091-A1 | TRANSLUCENT DEODORANT STICKS CONTAINING SOLUBILIZED 3,4,4'-TRICHLOROCARBANILIDE | THE DIAL CORPORATION (US) | 2011-12-08 | — | — | US | claimed |
| EP-4355433-A1 | SUSPENDING POLYMER COMPOSITION AND METHOD OF USE THEREOF | ISP Investments LLC (US) | 2024-04-24 | — | — | EP | disclosed |
| US-20230193160-A1 | A SUSPENDING POLYMER COMPOSITION, AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2023-06-22 | — | — | US | disclosed |
| US-20230167060-A1 | COMPOSITION AND METHODS FOR MODULATING A KINASE CASCADE | ATHENEX, INC. | 2023-06-01 | — | — | US | disclosed |
| EP-4157987-A1 | A SUSPENDING POLYMER COMPOSITION, AND METHOD OF USE THEREOF | ISP Investments LLC (US) | 2023-04-05 | — | — | EP | disclosed |
| WO-2023009315-A1 | A SUNSCREEN COMPOSITION COMPRISING AVOBENZONE AND A METHOD FOR PHOTOSTABILIZATION | ISP INVESTMENTS LLC (US) | 2023-02-02 | — | — | WO | disclosed |
| WO-2022266161-A1 | SUSPENDING POLYMER COMPOSITION AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2022-12-22 | — | — | WO | disclosed |
| WO-2021243198-A1 | A SUSPENDING POLYMER COMPOSITION, AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2021-12-02 | — | — | WO | disclosed |
| US-20190263755-A1 | COMPOSITION AND METHODS FOR MODULATING A KINASE CASCADE | KINEX PHARMACEUTICALS, LLC | 2019-08-29 | — | — | US | disclosed |
| US-9931290-B2 | Acrylate copolymer thickeners | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2018-04-03 | — | — | US | disclosed |
| WO-1999038486-A1 | COSMETIC COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1999-08-05 | — | — | WO | disclosed |
| WO-1999038485-A1 | COSMETIC COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1999-08-05 | — | — | WO | disclosed |
| WO-1998055089-A1 | COSMETIC COMPOSITIONS COMPRISING A PROTEINACEOUS MATERIAL AND A POLYOLESTER | THE PROCTER & GAMBLE COMPANY (US) | 1998-12-10 | — | — | WO | disclosed |
| WO-1998022075-A2 | COSMETIC COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-28 | — | — | WO | disclosed |
| EP-0706365-A4 | COSMETIC MAKE-UP COMPOSITIONS | PROCTER & GAMBLE (US) | 1998-03-25 | — | — | EP | disclosed |
| US-5688831-A | LIQUID CRYSTALS | THE PROCTER & GAMBLE COMPANY (US) | 1997-11-18 | — | — | US | disclosed |
| EP-0778765-A1 | COSMETIC MAKE-UP COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1997-06-18 | — | — | EP | disclosed |
| WO-1996011665-A1 | COSMETIC MAKE-UP COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1996-04-25 | — | — | WO | disclosed |
| EP-0706365-A1 | COSMETIC MAKE-UP COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1996-04-17 | — | — | EP | disclosed |
| WO-1994028860-A1 | COSMETIC MAKE-UP COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1994-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230167060-A1 | COMPOSITION AND METHODS FOR MODULATING A KINASE CASCADE | MAP3K1, MAP3K6, MAP3K11 | KMT2A 1990/4885MEN1 1821/4885LMNA 2550/4885 |
| US-20190263755-A1 | COMPOSITION AND METHODS FOR MODULATING A KINASE CASCADE | MAP3K1, MAP3K11, MAP3K6 | KMT2A 1568/4885MEN1 1654/4885LMNA 2522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.